Different Development Forms of Local Allergic Rhinitis towards Birch
Table 2
Combined symptom medication score (CSMS), symptom score, and medication score comparisons for the active and placebo patients at baseline and after AIT.
Parameter
Baseline
End of AIT
value
CSMS
Active
5.86 (3.79-9.34)
1.98 (1.30-3.1)
0.003
Placebo
5.94 (3.82-9.21)
4.98 (3.62-5.67)
0.14
Symptom score
Active
3.4 (2.74-6.19)
1.17 (0.81-1.58)
0.002
Placebo
3.7 (2.21-5.87)
3.39 (1.19-4.05)
0.34
Medication score
Active
2.03 (2.94-4.03)
0.45 (0.11-1.01)
0.04
Placebo
2.51 (1.98-4.31)
2.18 (1.33-3.76)
0.39
CSMS: combined symptom and medication score; the range is given in brackets.
